Skip to main content

Table 2 Clinical characteristics of patients with KPLA stratified by non-diabetic and diabetic with optimal glycemic control

From: The emergence of Klebsiella pneumoniae liver abscess in non-diabetic patients and the distribution of capsular types

  Non-DM
(n = 120)
DM with HbA1c < 7 %
(n = 19)
p
Age in years 64.1 ± 16.3 69.5 ± 12.9 0.166
Male 69 (57.5) 13 (68.4) 0.369
Charlson score 1.1 ± 1.8 2.0 ± 1.4 0.047
Underlying disease
 Malignancy 11 (9.2) 3 (15.8) 0.408
 Alcoholism 4 (3.3) 0 (0) 1.000
 Chronic kidney disease 4 (3.3) 3 (15.8) 0.054
 Liver cirrhosis 5 (4.2) 0 (0) 1.000
 Congestive heart failure 8 (6.7) 2 (10.5) 0.627
 Chronic lung disease 5 (4.2) 1 (5.3) 0.593
 Cerebrovascular accident 11 (9.2) 0 (0) 0.361
 APACHE II score 12.3 ± 6.9 14.9 ± 8.4 0.136
 Capsular type K1 and K2 94 (81.7)a 12 (75.0)b 0.506
 Wild-type antibiotic susceptibility 113 (94.2) 17 (89.5) 0.355
Origin 1.000
 Cryptogenic 103 (85.8) 17 (89.5)
 Biliary tract origin 17 (14.2) 2 (10.5)
Abscess location 0.937
 Right lobe 77 (64.2) 12 (63.2)
 Left lobe 21 (17.5) 4 (21.1)
 Both lobes 22 (18.3) 3 (15.8)
Abscess size 0.369
 <5 cm 51 (42.5) 6 (31.6)
 ≥5 cm 69 (57.5) 13 (68.4)
Gas-forming abscess 2 (1.7) 3 (15.8) 0.018
Multiple abscesses 18 (15.0) 3 (15.8) 1.000
Metastatic infection 6 (5.0) 1 (5.3) 1.000
Outcomes
 ICU admission 23 (19.2) 3 (15.8) 1.000
 Hospital days 26.9 ± 16.5 28.1 ± 21.1 0.786
 Mortality 4 (3.4) 0 (0) 1.000
  1. Data are presented as mean ± SD or frequency with percentage (%)
  2. a115 isolates were available for genotyping
  3. b16 isolates were available for genotyping